1.
Vicetti Miguel RD*, Quispe Calla NE, Dixon D, Foster RA, Gambotto A, Pavelko SD, Cherpes TL. IL-4-secreting eosinophils promote endometrial stromal cell proliferation and prevent Chlamydia-induced upper genital tract damage. Proc Natl Acad Sci USA 2017, 114(33): E6892-E6901.
2.
Vicetti Miguel RD*, Quispe Calla NE, Cherpes TL. Setting sights on Chlamydia immunity's central paradigm: can we hit a moving target? Infect Immun 2017, 85(7): e00129-17.
3.
Quispe Calla NE, Vicetti Miguel RD*, Prosper N Boyaka, Luanne Hall-Stoodley, Balveen Kaur, Wayne Trout, Pavelko SD, Cherpes TL. Medroxyprogesterone acetate and levonorgestrel increase
genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol 2016, 9(6): 1571-83.
4.
Vicetti Miguel RD*, Quispe Calla NE, Pavelko SD, Cherpes TL. Intravaginal Chlamydia trachomatis challenge infection elicits Th1 and Th17 immune responses in mice that promote pathogen clearance and genital tract damage. PLoS ONE 2016, 11(9): e0162445.
5.
Vicetti Miguel RD, Harvey S, LaFramboise WA, Reighard SD, Matthews DB & Cherpes TL. Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity. PLoS ONE 2013, 8(3): e58565.
6.
Vicetti Miguel RD, Hendricks RL, Aguirre AJ, Melan MA, Terry-Allison T, Thomson AW & Cherpes TL. Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection. J Immunol 2012, 189(7): 3449-61.
7.
Vicetti Miguel RD, Cherpes TL, Watson LJ, McKenna KC. CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination. J Immunol 2010, 185(11): 6706-18.
* Corresponding author
Complete list of publications:
https://www.ncbi.nlm.nih.gov/myncbi/1dSL8iSmv1Zkb/bibliography/public/
